A Phase I Trial of Vascular-Targeted Photodynamic Therapy in Esophagogastric Cancer Patients With Moderate to Severe Dysphagia
Latest Information Update: 01 Aug 2024
At a glance
- Drugs Padeliporfin (Primary)
- Indications Adenocarcinoma; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- 23 May 2023 Planned End Date changed from 1 Apr 2023 to 23 Feb 2025.
- 23 May 2023 Planned primary completion date changed from 1 Apr 2023 to 23 Feb 2025.
- 23 May 2023 Status changed from completed to active, no longer recruiting.